Donate
    Join Us

    Latest News

    Heading 1

    with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

    Heading 1

    with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

    Filter
    Select Category
    Research
    News
    Stories of Hope
    Family Conference
    PWS Registry
    Clinical Trials
    Clinical Issues
    Behavior & Mental Health
    Schaaf-Yang Syndrome
    Treatments
    Resource Development
    Endocrinology
    Hyperphagia
    Genetic Therapy
    Picture of FPWR

    FPWR
    Aardvark IPO Brings $94M to PWS Drug Development
    Aardvark Therapeutics achieved a major milestone last week by launching its initial public offering (IPO) and joining the NASDAQ as a publicly traded company (ticker symbol AARD). This marks an exciting step forward for Aardvark and for the entire Prader-Willi
    Resource for Parents: Helping Siblings Thrive in a PWS Family
    The challenges of Prader-Willi syndrome extend beyond the individual diagnosed to the entire family. Siblings growing up in a household with a person with PWS may need extra support to help them navigate their new normal and the unique family
    Help Drive Progress: Become an Advocate Reviewer for PWS Research
    A special contribution by guest blogger Will Greene. The future of PWS research depends on more than just scientists—it also needs the voices of parents, caregivers, and PWS advocates to guide meaningful progress. Becoming an Advocate Reviewer for FPWR is
    reflecting-on-2024-a-year-of-progress-promise-for-the-pws-community
    Reflecting on 2024: A Year of Progress & Promise for the PWS Community
    As 2024 draws to a close, we at the Foundation for Prader-Willi Research (FPWR) are reflecting on a year filled with progress, promise, and hope. This year’s achievements wouldn’t have been possible without the incredible dedication of our community—researchers, families,
    Questionnaire Measures Hyperphagia in PWS Clinical Trials
    Measuring hyperphagia is essential to developing and evaluating treatments for Prader-Willi syndrome (PWS). But because hyperphagia involves complex food-related thoughts and behaviors, researchers need tools specifically designed to capture these experiences. In 2016, Zafgen, Inc. donated its Hyperphagia Questionnaire for
    FDA Grants Rare Pediatric Disease Designation to CSTI-500
    The FDA has granted Rare Pediatric Disease Designation (RPDD) to ConSynance Therapeutics' new investigational drug, CSTI-500 for the treatment of Prader-Willi Syndrome in children and adolescents. This special status is granted to drugs and biologics intended to treat rare diseases,
    Previous 7 8 9 10 11

    Subscribe to hope.

    If you're looking for the latest information on Prader-Willi syndrome, you’ve come to the right place. FPWR Updates is your source for up-to-date information.

    Subscribe to FPWR News Updates

    Heading 1

    with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

    Evan and Dr. Fallah